Physician profile
Steven Maximus
NPI 1730478082
$140,119.59
in general payments reported to CMS, 2019-2025
26 companies · $60K in 2025
The $60K reported for 2025 was more than what 98% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,701 · 2020: $1,022 · 2021: $2,655 · 2022: $31K · 2023: $31K · 2024: $13K · 2025: $60K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $70K · Food and Beverage: $19K · Travel and Lodging: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $70,130.00 |
| Food and Beverage | $18,818.06 |
| Travel and Lodging | $11,581.34 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $82,619.14 | 2021-2025 | Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Silk Road Medical, INC. | $36,050.37 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Shockwave Medical, INC | $8,557.64 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cook Medical LLC | $3,751.17 | 2019-2025 | Cook, Zilver Ptx, Zenith Alpha |
| Medtronic, INC. | $1,943.58 | 2021-2025 | Endurant Iis, Valiant Captivia, Linq II |
| Boston Scientific Corporation | $1,547.17 | 2021-2025 | Jetstream Sc, Ranger, Ekosonic |
| Biotissue Holdings INC. | $1,046.80 | 2022-2023 | |
| Bard Peripheral Vascular, INC. | $1,008.89 | 2019-2025 | Rotarexs 6 F X 135 Cm |
| Medtronic Vascular, INC. | $588.84 | 2019 | |
| Terumo Medical Corporation | $495.41 | 2022-2024 | Glidesheath Slender, Tr Band, Hydropearl |
| Lemaitre Vascular, INC. | $467.71 | 2020-2025 | Artegraft Vascular Graft |
| Ge Healthcare | $408.85 | 2024-2025 | |
| Bolton Medical INC | $253.89 | 2024-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System, Tr Band |
| Cardiva Medical, INC. | $198.63 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 5f Vcs |
| Musculoskeletal Transplant Foundation INC. | $185.73 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $166.38 | 2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Smith+Nephew, INC. | $121.84 | 2025 | Stravix |
| Becton, Dickinson and Company | $121.83 | 2025 | Lifestream |
| Penumbra, INC. | $116.88 | 2023 | Indigo System |
| Checkpoint Surgical, INC | $102.68 | 2019 | |
| Lsi Solutions INC | $98.01 | 2022 | |
| Abbott Laboratories | $94.30 | 2025 | Esprit |
| Shape Memory Medical INC. | $70.56 | 2025 | Impede Embolization Plug |
| Endologix LLC | $62.88 | 2025 | Endocross Device, Torus Stent Graft System |
| Acell, INC. | $23.10 | 2020 | |
| Cagent Vascular INC | $17.31 | 2025 | Serrantor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Maximus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.